X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3034) 3034
humans (2867) 2867
oncology (1697) 1697
female (1448) 1448
male (1446) 1446
hematology (1404) 1404
middle aged (1338) 1338
adult (1184) 1184
chemotherapy (1022) 1022
aged (1000) 1000
treatment outcome (818) 818
antineoplastic combined chemotherapy protocols - therapeutic use (747) 747
stem-cell transplantation (722) 722
transplantation (708) 708
high-dose chemotherapy (692) 692
cancer (645) 645
multiple myeloma (610) 610
high-dose therapy (600) 600
dexamethasone (565) 565
care and treatment (552) 552
transplantation, autologous (507) 507
prognosis (465) 465
high-dose dexamethasone (430) 430
stem cells (426) 426
therapy (421) 421
multiple myeloma - therapy (406) 406
combined modality therapy (401) 401
medicine & public health (398) 398
double-blind (389) 389
bortezomib (387) 387
non-hodgkins-lymphoma (382) 382
bone-marrow-transplantation (378) 378
dexamethasone - administration & dosage (368) 368
high-dose melphalan (354) 354
multiple myeloma - drug therapy (353) 353
retrospective studies (353) 353
stem cell transplantation (343) 343
adolescent (342) 342
immunology (336) 336
antineoplastic agents - therapeutic use (334) 334
survival (331) 331
hematopoietic stem cell transplantation (327) 327
disease-free survival (310) 310
antineoplastic agents - adverse effects (305) 305
antineoplastic combined chemotherapy protocols - adverse effects (302) 302
pharmacology & pharmacy (293) 293
health aspects (276) 276
vomiting - chemically induced (276) 276
antineoplastic combined chemotherapy protocols - administration & dosage (269) 269
recurrence (269) 269
randomized-trial (268) 268
lymphomas (265) 265
research (261) 261
survival analysis (255) 255
medicine, general & internal (252) 252
survival rate (247) 247
abridged index medicus (246) 246
dexamethasone - therapeutic use (243) 243
vomiting - prevention & control (243) 243
animals (239) 239
hematology, oncology and palliative medicine (238) 238
high-dose metoclopramide (237) 237
cyclophosphamide (236) 236
rituximab (234) 234
antiemetics - therapeutic use (233) 233
bone-marrow transplantation (230) 230
salvage therapy (230) 230
risk factors (228) 228
high-dose methotrexate (227) 227
thalidomide (227) 227
analysis (225) 225
high-dose cisplatin (225) 225
remission induction (222) 222
nausea - chemically induced (220) 220
prevention (217) 217
autologous transplantation (214) 214
cyclophosphamide - administration & dosage (213) 213
nausea (211) 211
aged, 80 and over (209) 209
trial (209) 209
follow-up studies (207) 207
hematopoietic stem cell transplantation - methods (207) 207
young adult (207) 207
diagnosis (202) 202
hematopoietic stem cells (202) 202
child (195) 195
nausea - prevention & control (191) 191
multiple myeloma - mortality (188) 188
drug therapy (185) 185
melphalan (184) 184
drug therapy, combination (183) 183
phase-ii (181) 181
time factors (179) 179
drug administration schedule (177) 177
cisplatin (174) 174
multiple-myeloma (172) 172
ondansetron (172) 172
cisplatin-induced emesis (170) 170
high-dose methylprednisolone (169) 169
clinical trials as topic (167) 167
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3477) 3477
German (29) 29
French (15) 15
Spanish (14) 14
Russian (8) 8
Japanese (5) 5
Korean (5) 5
Italian (3) 3
Chinese (1) 1
Hungarian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
Blood, ISSN 0006-4971, 07/2012, Volume 120, Issue 1, pp. 9 - 19
Journal Article
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 11, pp. 1976 - 1981
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 14, pp. 2755 - 2762
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4621 - 4629
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1004 - 1010
Patients with relapsed aggressive non‐Hodgkin lymphoma (NHL) are often treated with platinum‐based chemoimmunotherapy regimens in preparation for autologous... 
B-CELL LYMPHOMA | ETOPOSIDE | PHASE-II | HIGH-DOSE CYTARABINE | CANDIDATES | HEMATOLOGY | SALVAGE REGIMEN | CHEMOTHERAPY | GEMCITABINE | TRANSPLANTATION | Recombinant Proteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Cytarabine - adverse effects | Recombinant Proteins - adverse effects | Filgrastim | Rituximab - therapeutic use | Organoplatinum Compounds - administration & dosage | Lymphoma, B-Cell - immunology | Female | Lymphoma, B-Cell - drug therapy | Rituximab - adverse effects | Granulocyte Colony-Stimulating Factor - adverse effects | Antigens, CD20 - immunology | Dexamethasone - administration & dosage | Lymphoma, B-Cell - mortality | Drug Administration Schedule | Polyethylene Glycols | Kaplan-Meier Estimate | Drug-Related Side Effects and Adverse Reactions - etiology | Granulocyte Colony-Stimulating Factor - therapeutic use | Cytarabine - administration & dosage | Recombinant Proteins - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rituximab - administration & dosage | Disease-Free Survival | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell - pathology | Aged | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Relapse | Pyrimidines | Dexamethasone | Cytarabine | Oncology, Experimental | Stem cells | Research | Cancer | Diseases | Steroids | Medical research | Autografts | Cytosine arabinoside | Toxicity | Rituximab | Neuropathy | Lymphoma | Oxaliplatin | Lymphocytes B | Platinum | CD20 antigen | Lymphomas | Cytosine | Hodgkin's disease | Index Medicus
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 10/2016, Volume 27, Issue 9, pp. 884 - 890
Journal Article